File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL

Conference Paper: PIN1 interacts with a specific serine-proline motif of hepatitis B virus X protein to enhance hepatocarcinogenesis

TitlePIN1 interacts with a specific serine-proline motif of hepatitis B virus X protein to enhance hepatocarcinogenesis
Authors
Issue Date2006
PublisherAmerican Association for Cancer Research.
Citation
The 97th Annual Meeting of the American Association for Cancer Research (AACR 2006), Washington, DC., 1-5 April 2006. In Cancer Research, 2006, v. 66 n. 8S, p. 351, abstract no. 1489 How to Cite?
AbstractBackground We previously reported overexpression of the peptidyl prolyl isomerase PIN1 in over 50% of hepatocellular carcinoma (HCC) cases related to hepatitis B virus (HBV) and its functional role in hepatocarcinogenesis. HBV X protein (HBx), a potent transactivator implicated in the pathogenesis of HBV-related HCC, has a potential PIN1 binding motif. We conducted a study to test the hypothesis that PIN1 may interact with HBx to exert a synergistic effect in HCC carcinogenesis. Methodology Sections of HCC specimens were immunostained for co-expression of PIN1 and HBx. The physical interaction between PIN1 and HBx was studied by co-immunoprecipitation (co-IP) and glutathione-S-transferase (GST) pull-down assays. Site-directed mutagenesis was performed to mutate either 1 or both pSer-Pro sites at amino-acid position 39 to 42 (-SerProSerPro-) of HBx. A total of 7 HBx mutants were generated, and the PIN1 binding site was determined by repeating co-IP and GST pull-down assays with the various HBx mutants. Subcellular localization of the two proteins was examined by immunofluorescence microscopy. The luciferase activity of an NF-AT driven reporter transactivated by HBx expression alone was compared with that transactivated by co-expression of HBx and PIN1 (wild type or mutants) to demonstrate their synergistic effect. Oncogenicity of a non-tumorigenic human liver cell line (MIHA) doubly transfected with PIN1 and HBx (wild type or mutants) was evaluated by soft agar assay and subcutaneous injection into nude mice, and compared with MIHA transfected with either PIN1 or HBx alone. Results PIN1 positively correlated with HBx expression (p=0.024) by immunohistochemistry in HBV-related HCCs. Immunofluorescence microscopy confirmed co-localization of HBx and PIN1 in the nucleus, and co-IP showed that PIN1 bound to ectopically expressed flag-tagged HBx in Hela cells. GST pull-down assay further validated the binding between the two proteins. Mutation of either Ser or Pro in the pSer41-Pro motif of HBx abolished its binding with PIN1. Co-transfection of PIN1 and HBx transactivated the NF-AT driven luciferase reporter, with two-fold increase in luciferase activity compared with transfection of HBx alone, or HBx mutants with abolition of Ser/Pro residues at the Ser41-Pro motif. Both colony formation and growth in soft agar were increased with stable PIN1-HBx transfectants compared with PIN1-HBx mutants at Ser41-Pro, PIN1 or HBx transfectants alone. Injection of PIN1-HBx transfectants in nude mice resulted in larger tumors compared with PIN1 or HBx transfectants alone. Conclusion Our study demonstrated that PIN1 interacts with a specific Ser-Pro motif of HBx and augments its transactivating activity and oncogenicity, implicating PIN1 expression as an important step in HBV-related hepatocarcinogenesis. PIN1 thus represents a novel molecular target for inhibition of hepatocarcinogenesis.
Persistent Identifierhttp://hdl.handle.net/10722/101954
ISSN
2015 Impact Factor: 8.556
2015 SCImago Journal Rankings: 5.372

 

DC FieldValueLanguage
dc.contributor.authorPang, RWCen_HK
dc.contributor.authorPoon, RTPen_HK
dc.contributor.authorLee, KWen_HK
dc.contributor.authorFan, STen_HK
dc.contributor.authorKwong, YLen_HK
dc.contributor.authorTse, EWCen_HK
dc.date.accessioned2010-09-25T20:11:10Z-
dc.date.available2010-09-25T20:11:10Z-
dc.date.issued2006en_HK
dc.identifier.citationThe 97th Annual Meeting of the American Association for Cancer Research (AACR 2006), Washington, DC., 1-5 April 2006. In Cancer Research, 2006, v. 66 n. 8S, p. 351, abstract no. 1489-
dc.identifier.issn0008-5472-
dc.identifier.urihttp://hdl.handle.net/10722/101954-
dc.description.abstractBackground We previously reported overexpression of the peptidyl prolyl isomerase PIN1 in over 50% of hepatocellular carcinoma (HCC) cases related to hepatitis B virus (HBV) and its functional role in hepatocarcinogenesis. HBV X protein (HBx), a potent transactivator implicated in the pathogenesis of HBV-related HCC, has a potential PIN1 binding motif. We conducted a study to test the hypothesis that PIN1 may interact with HBx to exert a synergistic effect in HCC carcinogenesis. Methodology Sections of HCC specimens were immunostained for co-expression of PIN1 and HBx. The physical interaction between PIN1 and HBx was studied by co-immunoprecipitation (co-IP) and glutathione-S-transferase (GST) pull-down assays. Site-directed mutagenesis was performed to mutate either 1 or both pSer-Pro sites at amino-acid position 39 to 42 (-SerProSerPro-) of HBx. A total of 7 HBx mutants were generated, and the PIN1 binding site was determined by repeating co-IP and GST pull-down assays with the various HBx mutants. Subcellular localization of the two proteins was examined by immunofluorescence microscopy. The luciferase activity of an NF-AT driven reporter transactivated by HBx expression alone was compared with that transactivated by co-expression of HBx and PIN1 (wild type or mutants) to demonstrate their synergistic effect. Oncogenicity of a non-tumorigenic human liver cell line (MIHA) doubly transfected with PIN1 and HBx (wild type or mutants) was evaluated by soft agar assay and subcutaneous injection into nude mice, and compared with MIHA transfected with either PIN1 or HBx alone. Results PIN1 positively correlated with HBx expression (p=0.024) by immunohistochemistry in HBV-related HCCs. Immunofluorescence microscopy confirmed co-localization of HBx and PIN1 in the nucleus, and co-IP showed that PIN1 bound to ectopically expressed flag-tagged HBx in Hela cells. GST pull-down assay further validated the binding between the two proteins. Mutation of either Ser or Pro in the pSer41-Pro motif of HBx abolished its binding with PIN1. Co-transfection of PIN1 and HBx transactivated the NF-AT driven luciferase reporter, with two-fold increase in luciferase activity compared with transfection of HBx alone, or HBx mutants with abolition of Ser/Pro residues at the Ser41-Pro motif. Both colony formation and growth in soft agar were increased with stable PIN1-HBx transfectants compared with PIN1-HBx mutants at Ser41-Pro, PIN1 or HBx transfectants alone. Injection of PIN1-HBx transfectants in nude mice resulted in larger tumors compared with PIN1 or HBx transfectants alone. Conclusion Our study demonstrated that PIN1 interacts with a specific Ser-Pro motif of HBx and augments its transactivating activity and oncogenicity, implicating PIN1 expression as an important step in HBV-related hepatocarcinogenesis. PIN1 thus represents a novel molecular target for inhibition of hepatocarcinogenesis.-
dc.languageengen_HK
dc.publisherAmerican Association for Cancer Research.-
dc.relation.ispartofCancer Researchen_HK
dc.titlePIN1 interacts with a specific serine-proline motif of hepatitis B virus X protein to enhance hepatocarcinogenesisen_HK
dc.typeConference_Paperen_HK
dc.identifier.emailPang, RWC: robertap@hku.hken_HK
dc.identifier.emailPoon, RTP: poontp@hkucc.hku.hken_HK
dc.identifier.emailLee, KW: tkwlee@hkucc.hku.hken_HK
dc.identifier.emailFan, ST: stfan@hku.hken_HK
dc.identifier.emailKwong, YL: ylkwong@hku.hken_HK
dc.identifier.emailTse, EWC: ewctse@hku.hken_HK
dc.identifier.authorityPoon, RTP=rp00446en_HK
dc.identifier.authorityLee, KW=rp00447en_HK
dc.identifier.authorityFan, ST=rp00355en_HK
dc.identifier.authorityKwong, YL=rp00358en_HK
dc.identifier.authorityTse, EWC=rp00471en_HK
dc.identifier.hkuros118623en_HK
dc.identifier.volume66-
dc.identifier.issue8S-
dc.identifier.spage351, abstract no. 1489-
dc.identifier.epage351, abstract no. 1489-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats